Literature DB >> 837489

The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man.

F I Marcus, E J Quinn, H Horton, S Jacobs, S Pippin, M Stafford, C Zukoski.   

Abstract

Seven subjects who underwent jejunoileal bypass surgery for massive obesity participated in a study to examine the relative bioavailability of digoxin before and one to two months after surgery. They were given a loading dose of 1 mg digoxin in divided oral doses followed by oral maintenance doses of 0.5 mg daily. There were no significant differences in the area under the serum concentration time curve, steady state serum levels or 24 hour steady state excretion of digoxin before and after surgery. We conclude that the bioavailability of digoxin from the Lanoxin tablets employed is not impaired in these patients, although urinary d-xylose and 24 hour fecal fat excretion indicated moderate to severe malabsorption after surgery.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837489     DOI: 10.1161/01.cir.55.3.537

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Systematic review of drug bioavailability following gastrointestinal surgery.

Authors:  Manuela Moreno Santamaría; José Javier Arenas Villafranca; Jimena Abilés; Alberto Fernández López; Lucia Visiedo Rodas; Begoña Tortajada Goitia; Pilar Utrilla Navarro
Journal:  Eur J Clin Pharmacol       Date:  2018-08-22       Impact factor: 2.953

Review 3.  Vitamin, mineral, and drug absorption following bariatric surgery.

Authors:  Ronald Andari Sawaya; Jane Jaffe; Lindsay Friedenberg; Frank K Friedenberg
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

4.  Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates.

Authors:  Lingtak-Neander Chan; Yvonne S Lin; Jessica C Tay-Sontheimer; Dorothy Trawick; Brant K Oelschlager; David R Flum; Kristen K Patton; Danny D Shen; John R Horn
Journal:  Pharmacotherapy       Date:  2015-03-10       Impact factor: 4.705

Review 5.  Drug interactions with digitalis glycosides.

Authors:  P F Binnion
Journal:  Drugs       Date:  1978-05       Impact factor: 9.546

Review 6.  Disease-related alterations in cardiac glycoside disposition.

Authors:  H R Ochs; D J Greenblatt; G Bodem; H J Dengler
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

7.  Absorption of penicillin and paracetamol after small intestinal bypass surgery.

Authors:  S I Terry; J C Gould; J P McManus; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

9.  Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.

Authors:  J P Kampmann; H Klein; B Lumholtz; J E Mølholm Hansen
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

10.  Lithium toxicity after Roux-en-Y bariatric surgery.

Authors:  Deanna Musfeldt; Andrew Levinson; Jennifer Nykiel; Gerardo Carino
Journal:  BMJ Case Rep       Date:  2016-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.